Abstract

Insights into the modes of action (MoAs) of xenobiotics are of utmost importance for the definition of adverse outcome pathways (AOPs), which are essential for a mechanism-based risk assessment. A well-established strategy to reveal MoAs of xenobiotics is the use of omics. However, often an even more comprehensive approach is needed, which can be achieved using multi-omics. Since the immune system plays a central role in the defense against foreign substances and pathogens, with the innate immune system building a first barrier, we systematically reviewed multi-omics studies investigating the effects of xenobiotics on macrophages. Surprisingly, only nine publications were identified, combining proteomics with transcriptomics or metabolomics. We summarized pathways and single proteins, transcripts, or metabolites, which were described to be affected upon treatment with xenobiotics in the reviewed studies, thus revealing a broad range of effects. In summary, we show that macrophages are a relevant model system to investigate the toxicological effects induced by xenobiotics. Furthermore, the multi-omics approaches led to a more comprehensive overview compared to only one omics layer with slight advantages for combinations that complement each other directly, e.g., proteome and metabolome.

Highlights

  • One step towards a facilitated risk assessment of xenobiotics is to identify approaches, which allow to decipher modes of action (MoAs)

  • Thereby, the statins acted via the pregnane X receptor (PXR), which is related to the detoxification of xenobiotics and has been shown to affect the induction of the NLR family pyrin domain containing 3 (NLRP3) inflammasome in endothelial cells [41] and macrophages [42]

  • Based on the here presented publications, the combination of proteome and metabolome seems to be preferable even though both combinations might be generally beneficial to decipher xenobiotics MoAs

Read more

Summary

Introduction

One step towards a facilitated risk assessment of xenobiotics is to identify approaches, which allow to decipher modes of action (MoAs). Xenobiotics can be a molecular initiating event (MIE), followed by causally related intermediate events, called key events (KEs), resulting in an adverse outcome (AO), which is referred to as adverse outcome pathway (AOP) [1]. Unravelling AOPs is relevant for risk assessment and the regulation of xenobiotics since it allows to understand undesirable effects better [1,2]

Immune Cells Are a Relevant Model System to Investigate Toxicity
The Innate Immune System Is the First Barrier against Foreign Substances
Omics Approaches Are Advantageous to Decipher the MoAs of Xenobiotics
Transcriptomics
Proteomics
Metabolomics
Methods
Results
Combination of Proteome and Transcriptome
Combination of Proteome and Metabolome
Discussion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call